Evidence for clinician underprescription of and patient non-adherence to guideline-recommended cardiovascular medications among adults with peripheral artery disease: protocol for a systematic review and meta-analysis

David de Launay,Maude Paquet,Aidan M Kirkham,Ian D Graham,Dean A Fergusson,Sudhir K Nagpal,Risa Shorr,Jeremy M Grimshaw,Derek J Roberts
DOI: https://doi.org/10.1136/bmjopen-2023-076795
IF: 3.006
2024-03-22
BMJ Open
Abstract:Introduction International guidelines recommend that adults with peripheral artery disease (PAD) be prescribed antiplatelet, statin and antihypertensive medications. However, it is unclear how often people with PAD are underprescribed these drugs, which characteristics predict clinician underprescription of and patient non-adherence to guideline-recommended cardiovascular medications, and whether underprescription and non-adherence are associated with adverse health and health system outcomes. Methods and analysis We will search MEDLINE, EMBASE and Evidence-Based Medicine Reviews from 2006 onwards. Two investigators will independently review abstracts and full-text studies. We will include studies that enrolled adults and reported the incidence and/or prevalence of clinician underprescription of or patient non-adherence to guideline-recommended cardiovascular medications among people with PAD; adjusted risk factors for underprescription of/non-adherence to these medications; and adjusted associations between underprescription/non-adherence to these medications and outcomes. Outcomes will include mortality, major adverse cardiac and limb events (including revascularisation procedures and amputations), other reported morbidities, healthcare resource use and costs. Two investigators will independently extract data and evaluate study risk of bias. We will calculate summary estimates of the incidence and prevalence of clinician underprescription/patient non-adherence across studies. We will also conduct subgroup meta-analyses and meta-regression to determine if estimates vary by country, characteristics of the patients and treating clinicians, population-based versus non-population-based design, and study risks of bias. Finally, we will calculate pooled adjusted risk factors for underprescription/non-adherence and adjusted associations between underprescription/non-adherence and outcomes. We will use Grading of Recommendations, Assessment, Development and Evaluation to determine estimate certainty. Ethics and dissemination Ethics approval is not required as we are studying published data. This systematic review will synthesise existing evidence regarding clinician underprescription of and patient non-adherence to guideline-recommended cardiovascular medications in adults with PAD. Results will be used to identify evidence-care gaps and inform where interventions may be required to improve clinician prescribing and patient adherence to prescribed medications. PROSPERO registration number CRD42022362801.
medicine, general & internal
What problem does this paper attempt to address?
The problem that this paper attempts to solve is the under - prescribing of guideline - recommended cardiovascular drugs by doctors for patients with peripheral artery disease (PAD) and the non - compliance of patients with these drugs. Specifically, the study aims to clarify the following aspects: 1. **Situations of under - prescribing by doctors and non - compliance by patients**: Evaluate the frequency of under - prescribing of guideline - recommended cardiovascular drugs by doctors in adult patients with PAD, as well as the non - compliance rate of patients with these drugs. 2. **Predictive factors**: Identify which patient characteristics and doctor characteristics can predict the under - prescribing by doctors and non - compliance by patients with guideline - recommended cardiovascular drugs. 3. **Association with adverse health and health system outcomes**: Explore whether the under - prescribing by doctors and non - compliance by patients with guideline - recommended cardiovascular drugs are related to adverse health outcomes (such as mortality, major cardiac and limb events, other diseases) and health system outcomes (such as medical resource use and cost). To achieve these goals, researchers will conduct a systematic review and meta - analysis. They will collect relevant literature by searching multiple databases (such as MEDLINE, EMBASE, and Evidence - Based Medicine Reviews) and use strict methods to evaluate the quality of the included studies. Ultimately, the research results will be used to identify the evidence - care gap in PAD patients and guide the implementation of interventions to improve the compliance of doctors in prescribing guideline - recommended drugs and the compliance of patients with drugs.